Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak

Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently

Topics
Bharat Biotech | COVID-19 | Coronavirus Vaccine

Press Trust of India 

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects, Haryana Health Minister Vij said

The human trial of Bharat Biotech's anti-vaccine Covaxin began at Rohtak's Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted.

Human trial with Corona vaccine (COVAXIN) of started at PGI Rohtak today, Vij, who is also the Home and Science & Technology minister said.

Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects, Vij further said in his tweet.

got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently.

There are over seven anti-corona vaccines at various stages of development in the country with two of them having received the drug regulator's go-ahead to start the human clinical trials of their vaccines.

Earlier this month, Zydus had said it has received approval from authorities to start human trials for its anti-vaccine.

Read our full coverage on Bharat Biotech
First Published: Fri, July 17 2020. 16:29 IST